Span America Med S (SPAN) 18.20 $SPAN Span-America

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Span America Med S (SPAN) 18.20 $SPAN

Span-America Declares Quarterly Cash Dividend
BusinessWire - Thu Aug 04, 3:20PM CDT
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that the Board of Directors declared a quarterly cash dividend of $0.16 per share. The dividend is payable September 7, 2016, to shareholders of record on August 16, 2016.
SPAN: 18.20 (+0.17)

Span-America Reports Third Quarter Fiscal 2016 Results
BusinessWire - Thu Aug 04, 3:12PM CDT
Span-America Medical Systems, Inc. (NASDAQ: SPAN) today reported its results for the third fiscal quarter ended July 2, 2016. Earnings per diluted share rose 6% to $0.34 in the third quarter of fiscal 2016 compared with $0.32 in the third quarter of fiscal 2015. Net income for the third quarter of fiscal 2016 was down 3% to $935,000 compared with $963,000 in the third quarter of fiscal 2015 due primarily to foreign currency losses in this year's third quarter compared with gains in the same quarter last year. Net sales for the third quarter of fiscal 2016 were down 3% to $15.3 million compared with $15.8 million in the third quarter of fiscal 2015.
SPAN: 18.20 (+0.17)

Span-America Reports Second Quarter 2016 Results
BusinessWire - Thu May 05, 3:15PM CDT
Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported its results for the second fiscal quarter ended April 2, 2016. Net income per diluted share rose 8% to $0.28 in the second quarter of fiscal 2016 compared with $0.26 in the second quarter of fiscal 2015. Net income for the second quarter of fiscal 2016 was down 2% to $758,000 compared with $773,000 in the second quarter of fiscal 2015 due primarily to foreign currency translation losses compared with the prior year's second quarter. Net sales for the second quarter of fiscal 2016 were down 1% to $14.9 million compared with $15.0 million in the second quarter of fiscal 2015.
SPAN: 18.20 (+0.17)

Span-America Announces Distribution Agreement for Australia
BusinessWire - Wed Apr 20, 3:15PM CDT
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that it has signed an exclusive agreement for the distribution of most of its line of medical beds and therapeutic support surfaces in Australia. The three-year agreement was signed with Alphacare, a leading supplier of healthcare and rehabilitation equipment in Australia. Alphacare's initial order of approximately USD $270,000 has already been completed.
SPAN: 18.20 (+0.17)

Span-America Medical Systems To Release Second Quarter Fiscal 2016 Results On May 5, 2016
PR Newswire - Mon Apr 18, 11:30AM CDT
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced that it plans to release its fiscal 2016 second quarter results on Thursday, May 5, after the close of regular trading.
SPAN: 18.20 (+0.17)

Span-America Announces Changes in Consumer Bedding Business
BusinessWire - Wed Apr 13, 3:15PM CDT
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that it expects lower consumer bedding sales during the remainder of fiscal 2016 and the first half of fiscal 2017 based on recent competitive changes and an increased emphasis on the Company's medical products segment.
SPAN: 18.20 (+0.17)

Span-America Medical Systems To Release First Quarter Fiscal 2016 Results On February 4, 2016
PR Newswire - Mon Jan 25, 11:42AM CST
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced that it plans to release its fiscal 2016 first quarter results on Thursday, February 4, after the close of regular trading.
SPAN: 18.20 (+0.17)

Span-America Reports Improved Fourth Quarter and Fiscal Year 2015 Results
BusinessWire - Mon Nov 09, 3:30PM CST
--Net Income Jumps 96% to $1.3 Million, or $0.43 Per Diluted Share
SPAN: 18.20 (+0.17)

Span-America Medical Systems To Release Fourth Quarter Fiscal 2015 Results On November 9, 2015
PR Newswire - Mon Nov 02, 3:45PM CST
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced that it plans to release its fiscal 2015 fourth quarter results on Monday, November 9, after the close of regular trading.
SPAN: 18.20 (+0.17)

Span-America repurchases 261,310 common stock from former director and affiliate
M2 - Mon Oct 05, 4:48AM CDT
Medical pressure management company Span-America Medical Systems (NasdaqGM:SPAN) disclosed on Friday the buy back of 261,310 common stock for USD4.6mn.
SPAN: 18.20 (+0.17)

Span-America Repurchases 261,310 Shares from Former Director Robert B. Johnston and the Jerry Zucker Revocable Trust
BusinessWire - Fri Oct 02, 3:15PM CDT
Span-America Medical Systems, Inc. (NASDAQ:SPAN) announced today that it has repurchased 261,310 shares of its common stock (approximately 9% of the outstanding shares) from Robert B. Johnston and his affiliate, The Jerry Zucker Revocable Trust, for $4.6 million. The repurchase includes 12,000 shares owned by Mr. Johnston and 249,310 shares owned by The Jerry Zucker Revocable Trust. The Company also announced that Mr. Johnston resigned from the Company's Board of Directors following the sale of the stock to the Company. Mr. Johnston was first elected as a Span-America director in 2004 pursuant to an Agreement between the Company, Jerry Zucker and Mr. Johnston. Mr. Johnston advised the Company that he was resigning because he and his affiliates ceased to own any Span-America stock.
SPAN: 18.20 (+0.17)

Span-America Reports Improved Third Quarter 2015 Results
BusinessWire - Wed Aug 05, 3:10PM CDT
--Net Income Jumps 155% to $0.32 Per Diluted Share
SPAN: 18.20 (+0.17)

Span-America Increases Quarterly Cash Dividend by 6.7%
BusinessWire - Wed Jul 29, 9:30AM CDT
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced today that the Board of Directors increased the quarterly cash dividend to $0.16 per share, an increase of 6.7% from the previous quarterly dividend of $0.15 per share. The dividend is payable September 3, 2015, to shareholders of record on August 18, 2015.
SPAN: 18.20 (+0.17)

Span-America Medical Systems To Release Third Quarter 2015 Results On August 5, 2015
PR Newswire - Wed Jul 22, 10:00AM CDT
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced that it plans to release its fiscal 2015 third quarter results on Wednesday, August 5, after the close of regular trading.
SPAN: 18.20 (+0.17)

Span-America's Consumer Bedding Products Selected for Major Retailer's Seasonal Promotion
BusinessWire - Tue Jun 09, 3:15PM CDT
Span-America Medical Systems, Inc. (NASDAQ:SPAN) announced that it was notified by a major retail customer that the Company has been selected as a supplier of consumer bedding products for the retailer's seasonal promotion in the fall of 2015. The Company expects that the promotion will be comparable in size to the promotions in which Span-America participated during the fall seasons of fiscal years 2012 and 2013. Span-America did not participate in a seasonal promotion in fiscal year 2014.
SPAN: 18.20 (+0.17)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 9

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

A Comprehensive Look at Apple's Competitive Position in Tech

Updated Category News Views 313

Understanding Apple's Competitive Landscape In today's dynamic business environment, a deep-dive analysis of top companies is essential for investors and industry insiders. This examination will focus on Apple (AAPL), alongside its chief rivals in the Technology Hardware, Storage & Peripherals sector. By analyzing crucial financial indicators, market positioning, and...

Continue Reading
Cegedim Shares Insights on Latest Liquidity Contract Performance

Updated Category News Views 135

Overview of Cegedim's Liquidity Contract Statement This article covers the latest updates on Cegedim’s liquidity contract performance, highlighting significant figures and trends that reflect the company's financial health. Cegedim has established a robust liquidity contract with Rothschild Martin Maurel, aimed at promoting transparency and liquidity in its shares. Key...

Continue Reading
Silexion Therapeutics Advances SIL204 for Pancreatic Cancer

Updated Category News Views 136

Silexion Therapeutics Moves Forward with SIL204 Silexion Therapeutics Corp. (NASDAQ: SLXN) is celebrating a significant milestone with the completion of crucial toxicology studies for its innovative RNA silencing therapy, SIL204. This groundbreaking therapy, designed to target mutated KRAS oncogenes, has shown no signs of systemic organ toxicity, reinforcing the...

Continue Reading
Emerson Partners with LifeSight for Enhanced Pension Solutions

Updated Category News Views 178

Emerson Partners with LifeSight for Pension Solutions LifeSight, WTW’s UK defined contribution (DC) master trust, has stepped into a significant role by becoming the full master trust provider for Emerson, the advanced electronics powerhouse. This partnership aims to cover all active, deferred, and drawdown members effectively, ensuring they are well-accommodated in...

Continue Reading
Howard Marks Joins Alliance for Decision Education Board

Updated Category News Views 227

Exciting News from the Alliance for Decision Education The Alliance for Decision Education is thrilled to announce an important addition to its Board of Directors. Howard Marks, a leader in investment management and a well-respected voice in decision-making, has agreed to join the board. As the co-chairman and co-founder of Oaktree Capital Management, Marks brings with...

Continue Reading